Cargando…
Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer
Current vascular-targeted therapies in colorectal cancer (CRC) have shown limited benefit. The lack of novel, specific treatment in CRC has been hampered by a dearth of specific endothelial markers. Microarray comparison of endothelial gene expression in patient-matched CRC and normal colon identifi...
Autores principales: | Ferguson, Henry J.M., Wragg, Joseph W., Ward, Stephen, Heath, Victoria L., Ismail, Tariq, Bicknell, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991466/ https://www.ncbi.nlm.nih.gov/pubmed/26943033 http://dx.doi.org/10.18632/oncotarget.7812 |
Ejemplares similares
-
An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
por: Robinson, Joseph, et al.
Publicado: (2020) -
Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012) -
A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes
por: Herbert, John MJ, et al.
Publicado: (2008) -
Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015) -
Expression and roles of glutamate (NMDA) receptors on T cell subsets
por: Orihara, Kanami, et al.
Publicado: (2010)